From the webinar, i get the impression that they are not going to get any revenue until Q2 2025... FDA for heart failure is also around Q2 / Q3 2025. Can anyone comment on that? Just want to cross validate my understanding from the webinar.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $141.9M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 22.0¢ | $426.6K | 1.889M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 525862 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 200000 | 2 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |